Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Brainstorm Cell Therapeutics Inc (BCLI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Brainstorm Cell Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.378 -0.162    -30.04%
16:00:01 - Closed. Currency in USD ( Disclaimer )
After Hours
0.420
+0.042
+11.005%
19:58:19 - Real-time Data
  • Volume: 1,715,123
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.360 - 0.559
Type:  Equity
Market:  United States
Brainstorm Cell Therapeutics 0.378 -0.162 -30.04%

Brainstorm Cell Therapeutics Inc Company Profile

 
Get an in-depth profile of Brainstorm Cell Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

43

Equity Type

ORD

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Contact Information

Address 1325 Avenue of Americas 28th Floor
New York, 10019
United States
Phone 201 488 0460
Fax -

Top Executives

Name Age Since Title
Jacob Ahron Frenkel 78 2007 Independent Chairman of the Board
Andrew Hill Card 73 2011 Member of Business Advisory Board
Rasheda Ali - 2007 Member of Business Advisory Board
Irit Arbel 63 2004 Co-Founder & Independent Vice Chair of the Board
Jerold Chun - 2018 Chairman of Scientific Advisory Board
Nir Naor 49 2023 Independent Director
Stanley H. Appel 90 - Member of Scientific Advisory Board
Menghisteab Bairu 62 2021 Independent Director
Amit Bar-Or - - Member of Scientific Advisory Board
Ralph Z. Kern 65 2017 Member of Scientific Advisory Board
Anthony J. Polverino 60 2018 Independent Director
Uri Yablonka 47 2014 Executive VP, Chief Business Officer, Secretary & Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BCLI Comments

Write your thoughts about Brainstorm Cell Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Laith Bee
BearMountain Nov 20, 2020 23:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
your bets please
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email